Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance - Garcia, A.L; Otto, B; Reich, S.C; Weickert, M.O; Steiniger, J; Machowetz, A; Rudovich, N.N; Mohlig, M; Katz, N; Speth, M (European journal of clinical nutrition, 2007)
Keywords: administration & dosage; Adults; Aged; arabinoxylan; Arabinoxylans; Area Under Curve; Biological and medical sciences; blood; blood glucose; Blood Glucose - metabolism; Body mass index; Body size; Clinical Nutrition; Consumption; Cross-Over Studies; Diabetes; Diabetes mellitus; Diabetes. Impaired glucose tolerance; Diet; dietary carbohydrate; Dietary Fiber; Dietary Fiber - administration & dosage; Dietary Supplements; Diseases of the digestive system; drug therapy; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Epidemiology; Etiopathogenesis. Screening. Investigations. Target tissue resistance; experimental diets; Female; Ghrelin; Glucose; Glucose Intolerance; Glucose Intolerance - blood; Glucose Intolerance - drug therapy; Glucose Intolerance - metabolism; Glucose tolerance; Hormones; Humans; Insulin; Insulin - blood; Internal Medicine; Intervention; Male; Medical sciences; Medicine; Medicine & Public Health; men; Metabolic Diseases; Metabolic response; metabolic studies; Metabolism; Middle Aged; Nutrition; nutritional intervention; original-article; Peptide Hormones; Peptide Hormones - blood; Placebos; Plasma; Postprandial Period; postprandial state; Public Health; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects); Single-Blind Method; Solubility; Time Factors; triacylglycerols; Triglycerides; Triglycerides - blood; women; Xylans; Xylans - administration & dosage; impaired glucose tolerance; ghrelin; soluble dietary fibre; Endocrinopathy; Consumption; Human; Pancreatic hormone; Postprandial; Soluble form; Glucose; Insulin; Feeding; Appetite stimulant; Diet therapy; Ghrelin; Serum; Biological effect; Impaired glucose tolerance; Arabinoxylan